Shikonin Modulates Cell Proliferation by Inducing Apoptosis in LLC Cells via MAPK Regulation and Caspase Activation
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Abstract
Shikonin is a chemically characterized component of traditional herbal medicine, the root of Lithospermum erythrorhizon and has been shown to possess antitumor activities. Here we investigated anticancer potential of shikonin and its possible mechanism of action in LLC cells. Shikonin inhibited the proliferation of LLC cells in a concentration-dependent manner. It was also demonstrated that shikonin induced apoptosis in LLC cells by Annexin V staining and TUNEL staining analysis. Shikonin treatment was caused that decrease of Bcl-2, activation of caspases and cleavage of PARP. And shikonin also induced that the activation of mitogen-activated protein kinases (MAPKs), such as extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38. Interestingly, the cell proliferation inhibition induced by shikonin was recovered by specific inhibitors of JNK and p38 but the inhibitor of MEK, the upstream kinase of ERK, did not recover. Additionally, shikonin administration at doses of 5 mg/kg in C57BL/6 mice strongly inhibited the primary tumor growth of LLC. Taken together, these results suggest that shikonin may suppress LLC cell proliferation by inducing an apoptotic process via activation of caspases and MAPKs
참고문헌 (29)
- "Apoptosis in the pathogenesis and treatment of disease", 267, pp.1456~1462 (1995)
- "Apoptosis regulators and their role in tumorigenesis", 1551, pp.1~37 (2001)
- "Molecular mechanisms of the decision between life and death regulation of apoptosis by apoptosis signal-regulating kinase 1", 130, pp.1~8 (2001)
- "Programmed cell death in animal development", 88, pp.347~354 (1997)
- "Induction of apoptosis by cancer chemotherapy", 256, pp.42~49 (2000)
- "Therapeutic applications of apoptosis research", 256, pp.1~11 (2000)
- "Topoisomerase inhibitors induce apoptosis in thymocytes", pp.147~54 (1993)
- "Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors", pp.388~397 (1993)
- "Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes", pp.2133~
- "Involvement of the CD95 receptor", ligand system in drug-induced apoptosis in leukemia cells, 1996, pp.2, 574~577
- "Taxol-induced apoptosis depends on MAP kinase pathways and is independent of p53", 20, pp.147~155 (2001)
- "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis", 270, pp.1326~1331 (1995)
- "Antitumor activity of shikonin and its derivatives", pp.2392~2395 (1977)
- "Accelerative effect of shikonin alkannin and acetylshikonin on the proliferation of granulation tissue in rats", pp.1075~1077 (1994)
- "A comparative study on anti-inflammatory activities of the enantiomers", pp.466~469 (1986)
- "an ingredient of Lithospermum erythrorhizon induced apoptosis in HL60 human premyelocytic leukemia cell line", 65, pp.532~535 (1999)
- "Direct reaction between shikonin and thiols induces apoptosis in HL60 cells", 25, pp.827~832 (2002)
- "synthesis and inhibition of DNA topoisomerase-I", 38, pp.1044~1047 (1995)
- "Induction of topoisomerase II-mediated DNA cleavage by the plant naphthoquinones plumbagin and shikonin", pp.2589~2594 (1992)
- "beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide", 125, pp.17~23 (1999)
- "Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells", 200, pp.115~121 (2003)
- "Clinical trial on the effects of shikonin mixture on later stage lung cancer", pp.598~599 (1991)
- "antitumor action against ICR mice bearing ascitic S-180 cells", 24, pp.35~38 (2001)
- "A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt", 19, pp.1518~1520 (1996)
- "From bench to clinic with apoptosis-based therapeutic agents", 407, pp.810~407 816 (2000)
- "Bcl-2 heterodimerizes in vivo with a conserved homolog", pp.609~619 (1993)
- "Involvement of caspase-3 activation in squamocin-induced apoptosis in leukemia cell line HL-60", 70, pp.1259~1269 (2002)
- "Signal transduction through MAP kinase cascades", 74, pp.49~139 (1998)
- "Roles of JNK p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium", 21, pp.1423~1432 (2000)
